Depressive Disorder: all 4,847 studies
Page 45 of 49. Open to participants first (509), then studies with results posted, then the rest; newest registration first within each.
- St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid AnxietyCompletedNCT00451516Phase 2
- The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive DisorderWithdrawnNCT00451490Not applicable
- A Efficacy Study of PRX-00023 in Patients With Major Depressive DisorderCompletedNCT00448292Phase 2
- A Study Of New Medicine (GSK 372475) For The Treatment Of DepressionCompletedNCT00448058Phase 2
- Safety and Antidepressant Effects of Rellidep in Major Depressive DisorderCompletedNCT00446719Phase 2/3
- Evaluating the Benefits and Affordability of a Program to Improve the Care of Common Mental Disorders in Primary CareCompletedNCT00446407Not applicable
- Evaluation of Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major DepressionCompletedNCT00445237Phase 1
- Evaluation of the H-Coil Transcranial Magnetic Stimulation (TMS) Device in the Treatment of Bipolar DepressionCompletedNCT00444938Phase 1
- Diagnosis of Depression Among AdolescentsCompletedNCT00443742
- Escitalopram and Sleep Architecture in Patients With Major Depressive DisorderStatus unknownNCT00442481Phase 4
- Morbidity and Mortality Among Dialysis Patients After Treatment for DepressionStatus unknownNCT00442429
- Treatment Resistant Depression and Obstructive Sleep Apnea, Effect of Continuous Positive Airway Pressure (CPAP)Status unknownNCT00441636Not applicable
- Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR)CompletedNCT00440427Phase 1
- A Study To Evaluate The Effect Of WELLBUTRIN XL On Intraocular PressureCompletedNCT00439868Phase 1
- Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing DisordersCompletedNCT00438685Phase 1
- rEEG Guided Pharmacotherapy of Subjects With Depression Treatment FailureCompletedNCT00437827Not applicable
- Evaluation of Three Continuation Therapies After ECT Concerning Efficacy and Cognition in Severly Depressed PatientsCompletedNCT00437385Phase 1
- Interpersonal Therapy-Based Treatment to Prevent Postpartum Depression in Adolescent MothersCompletedNCT00436150Not applicable
- Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy MalesCompletedNCT00435695Phase 1
- A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and InsomniaCompletedNCT00435279Phase 3
- Screening for Mental Health Concerns for at-Risk Community Living Chinese SeniorsStatus unknownNCT00433238Phase 1
- Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive DisorderCompletedNCT00432614Phase 3
- Screening and Treatment of Depression in the CommunityCompletedNCT00430404Phase 4
- Hormonal Levels in Men With Major Depressive DisorderWithdrawnNCT00429689
- A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With DepressionCompletedNCT00429260Phase 3
- Prozac Treatment of Major Depression: Discontinuation StudyCompletedNCT00427128Phase 4
- To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.CompletedNCT00426608Phase 1
- Galantamine Augmentation of Escitalopram for Treatment of DepressionTerminatedNCT00423969Phase 4
- Phase III/Seroquel SR Bipolar Depression Monotherapy - USCompletedNCT00422214Phase 3
- Augmentation of the Antidepressant Action of Sertraline With Triiodothyronine (T3)and Reboxetine: Clinical Efficacy, Adverse Effects and Predictors of Response.CompletedNCT00421369Not applicable
- Escitalopram in Depressive Patients With Acute Coronary Artery SyndromeCompletedNCT00419471Phase 4
- An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive DisorderCompletedNCT00415142Phase 3
- Using Learning Teams for Reflective Adaptation for Diabetes and DepressionCompletedNCT00414986Not applicable
- Evaluation of the Effects of Duloxetine on NorepinephrineCompletedNCT00414323Phase 1
- Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)CompletedNCT00413023Phase 2
- Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive DisorderCompletedNCT00411242Phase 3
- Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive DisorderCompletedNCT00411099Phase 3
- D-cycloserine for Major Depressive DisorderCompletedNCT00408031Phase 2
- Study for Evaluating Different Methods of Measuring Depression Treatment ResponseCompletedNCT00406952Not applicable
- A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese SubjectsCompletedNCT00406432Phase 1
- Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese SubjectsCompletedNCT00406003Phase 1
- Depression Screening in Patients With Lung CancerCompletedNCT00404365Not applicable
- Use of Omega-3 Fatty Acids for Perinatal DepressionCompletedNCT00402389Phase 2
- A Double-blind Sham Controlled Trial of rTMS in Treatment Resistant Major DepressionCompletedNCT00402220Not applicable
- Lithium Versus Paroxetine in Patients With Major Depression Who Have a Family History of Bipolar Disorder or SuicideTerminatedNCT00400088Phase 3
- Antidepressant Safety in Kids StudyCompletedNCT00395213
- Somatosensory Processing in DepressionWithdrawnNCT00386893Phase 4
- Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive DisorderCompletedNCT00385437Phase 2
- Study of Home-Based Exercise to Alleviate Postpartum DepressionCompletedNCT00384943Not applicable
- Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed PatientsCompletedNCT00384436Phase 4
- Effects of Interpersonal Psychotherapy on Depression During and After PregnancyCompletedNCT00380419Not applicable
- Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive DisorderTerminatedNCT00380042Phase 1
- Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant MedicationCompletedNCT00375843Phase 4
- Preventing Depression Recurrence in DiabetesCompletedNCT00374426Phase 4
- Cradling Our Future Through Family Strengthening StudyCompletedNCT00373750Not applicable
- A Study of the Cost Effectiveness of Generalist Care Managers for Depression Treatment in Medicaid RecipientsCompletedNCT00373477Not applicable
- Postpartum Depression and Cesarean SectionCompletedNCT00370903
- Study on the Influence of Electroconvulsive Therapy (ECT) on Homocysteine LevelsCompletedNCT00370058Phase 4
- Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed PatientsCompletedNCT00369798Phase 1
- Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.CompletedNCT00368862Phase 4
- A Local Register Study For Major Depression Of Paroxetine Controlled ReleaseCompletedNCT00368303Phase 3
- A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive DisorderCompletedNCT00368030Phase 3
- Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy SubjectsCompletedNCT00366652Phase 3
- A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar DepressionCompletedNCT00363337Phase 4
- An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive DisorderCompletedNCT00361491Phase 2
- Effectiveness of School-Based Cognitive Behavioral Therapy in Preventing Depression in Young AdolescentsCompletedNCT00360451Phase 3
- Genetic Study of Liver Enzymes in Patients With Side Effects From AntidepressantsCompletedNCT00360256
- RU-486 in the Treatment of Bipolar DepressionWithdrawnNCT00359125Phase 2
- An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive DisorderCompletedNCT00358631Phase 2
- Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of ParoxetineCompletedNCT00357045Phase 4
- The ACHIEVA Study of Enhanced Pharmacist Care on Antidepressant Use and ResponseTerminatedNCT00356655Not applicable
- Interpersonal Psychotherapy for Depression in People With Heart FailureCompletedNCT00353223Phase 1/2
- Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and AdolescentsCompletedNCT00353028Phase 4
- Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive DisorderCompletedNCT00351910Phase 3
- Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive DisorderCompletedNCT00351169Phase 3
- A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive DisorderCompletedNCT00345098Phase 3
- PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety PatientsCompletedNCT00343707Phase 2
- Functional Neuroimaging in DepressionCompletedNCT00343070Phase 2
- Effect of Brain Lesion Severity on Treatment Response in Late-Life DepressionCompletedNCT00339066Not applicable
- The Effect of Duloxetine on Interoceptive AwarenessStatus unknownNCT00337012
- A 24-52-week Study to Evaluate the Long-term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)CompletedNCT00336713Phase 3
- A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.Status unknownNCT00335205Phase 4
- Light Therapy for Elderly DepressionTerminatedNCT00332670Phase 2/3
- Exercise Training Versus Drug Therapy for Treating Depression in Older AdultsCompletedNCT00331305Phase 3
- Primary Prevention of Major Depression in Later LifeCompletedNCT00326677Not applicable
- Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive DisordersCompletedNCT00326144Phase 3
- Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive DisordersCompletedNCT00326105Phase 3
- Phase II Study to Assess RG2417 in the Treatment of Bipolar I DepressionCompletedNCT00322764Phase 2
- Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive DisorderCompletedNCT00321490Phase 3
- A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant Outpatients With Major Depressive Disorder (MDD)CompletedNCT00321152Phase 4
- Desipramine for Improving Cellular Signaling and Decreasing Symptoms of Major DepressionCompletedNCT00320632Phase 4
- Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive DisorderCompletedNCT00320268Phase 3
- An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With DepressionCompletedNCT00319709Phase 3
- RCT of Psychoeducational Program of DepressionCompletedNCT00319540Phase 2
- Nicotinic Receptor Augmentation of SSRI AntidepressantsCompletedNCT00319319Phase 2
- Trial of Citalopram for the Prevention of DepressionCompletedNCT00317746Phase 3
- Integrated Parent Training for Treating Depression in Mothers of Children With Attention Deficit Hyperactivity DisorderCompletedNCT00316290Not applicable
- Sexual Functioning Study With AntidepressantsCompletedNCT00316160Phase 4
- Telemedicine or Standard Care in Treating Patients With Depression and/or Pain Caused By CancerStatus unknownNCT00313573Phase 3
- Creatine as a New Therapeutic Strategy in DepressionTerminatedNCT00313417Phase 4